A novel oxygen carrier “YQ23” suppresses the liver tumor metastasis by decreasing circulating endothelial progenitor cells and regulatory T cells

BACKGROUND: Surgical therapies are the first-line treatments for hepatocellular carcinoma (HCC) patients. However, the high incidence of tumor metastasis after liver surgery remains a severe problem. We aim to investigate the roles and the underlying mechanism of YQ23, stabilized non-polymeric diasp...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Li, Chang Xian, Wong, Bing L, Ling, Chang Chun, Ma, Yuen Yuen, Shao, Yan, Geng, Wei, Qi, Xiang, Lau, Sze Hang, Kwok, Sui Yi, Wei, Na, Tzang, Fei Chuen, Ng, Kevin TP, Liu, Xiao Bing, Lo, Chung Mau, Man, Kwan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2014
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4006450/
https://ncbi.nlm.nih.gov/pubmed/24766798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-293
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller